Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...

Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, recently presented data demonstrating ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...

More than 200 community health agents have already been trained in Burundi to help control the spread of mpox as the ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...

Tanzania has officially declared the end of an outbreak of Marburg virus disease that hit the northwestern Kagera region in January. But officials are still bracing for the ongoing threat of Mpox.

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.